Dutcher J P, Salva K M, Wiernik P H
Department of Oncology, Montefiore Medical Center, Bronx, New York 10467.
Am J Clin Oncol. 1990 Aug;13(4):290-3. doi: 10.1097/00000421-199008000-00004.
Two patients with hairy cell leukemia (HCL) who failed alpha-2a-interferon and one who failed beta-ser-interferon were treated with 2'-deoxycoformycin (DCF), 4 mg/m2, by intravenous bolus infusion every 2 weeks. All three patients achieved a complete response, continuing for 9+, 14+, and 15+ months. Treatment was discontinued when complete remission was diagnosed. DCF-induced remission has not been previously reported after beta-ser-interferon failure. These patients, as well as 12 others in the literature reviewed herein, demonstrate the efficacy of DCF in HCL patients unresponsive to alpha, beta, and gamma interferon.
两名对α-2a干扰素治疗无效的毛细胞白血病(HCL)患者和一名对β-丝氨酸干扰素治疗无效的患者接受了2'-脱氧助间型霉素(DCF)治疗,剂量为4mg/m²,每2周静脉推注一次。所有三名患者均获得完全缓解,持续时间分别为9个多月、14个多月和15个多月。确诊完全缓解后停止治疗。此前尚无β-丝氨酸干扰素治疗失败后DCF诱导缓解的报道。本文回顾的文献中的这3名患者以及其他12名患者均表明,DCF对α、β和γ干扰素无反应的HCL患者有效。